KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Current Deferred Revenue (2016 - 2022)

Historic Current Deferred Revenue for Inovio Pharmaceuticals (INO) over the last 14 years, with Q2 2022 value amounting to $9.0 million.

  • Inovio Pharmaceuticals' Current Deferred Revenue rose 813126.88% to $9.0 million in Q2 2022 from the same period last year, while for Jun 2022 it was $9.0 million, marking a year-over-year increase of 813126.88%. This contributed to the annual value of $21628.0 for FY2021, which is 5361.59% down from last year.
  • Inovio Pharmaceuticals' Current Deferred Revenue amounted to $9.0 million in Q2 2022, which was up 813126.88% from $15378.0 recorded in Q1 2022.
  • Inovio Pharmaceuticals' Current Deferred Revenue's 5-year high stood at $24.1 million during Q1 2018, with a 5-year trough of $14853.0 in Q2 2020.
  • In the last 5 years, Inovio Pharmaceuticals' Current Deferred Revenue had a median value of $99232.0 in 2019 and averaged $2.1 million.
  • As far as peak fluctuations go, Inovio Pharmaceuticals' Current Deferred Revenue tumbled by 9954.05% in 2019, and later skyrocketed by 813126.88% in 2022.
  • Inovio Pharmaceuticals' Current Deferred Revenue (Quarter) stood at $1.1 million in 2018, then crashed by 91.33% to $92353.0 in 2019, then plummeted by 49.51% to $46628.0 in 2020, then crashed by 53.62% to $21628.0 in 2021, then skyrocketed by 41432.36% to $9.0 million in 2022.
  • Its Current Deferred Revenue stands at $9.0 million for Q2 2022, versus $15378.0 for Q1 2022 and $21628.0 for Q4 2021.